Safety Pharmacology

As part of an IND-enabling programme, safety Pharmacology evaluations are an essential step in assessing acute and potentially life-threatening risks of novel pharmaceuticals. Charles River experts devote time to risk mitigation by evaluating programmes in the discovery/lead optimisation phase, saving time in the preclinical phase of development. Learn from the CRO where 25% of the world's Diplomates in Safety Pharmacology (DSPs) have chosen to pursue a career

Related Conference of Pharmaceutical Sciences